SCHEMBL7874059

SCHEMBL7874059

COCC(C=O)OC

nearest known ligand 0.00

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL17816366 1.00
SCHEMBL10067006 0.79
SCHEMBL11125110 0.77
SCHEMBL4048543 0.76
SCHEMBL13922054 0.76
SCHEMBL1392324 0.74
SCHEMBL10918298 0.74
SCHEMBL13412034 0.74
SCHEMBL10067007 0.73 MPI (0.32)
SCHEMBL10067041 0.73 MPI (0.32)

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 18 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-9861652-B2 2′ Fluoronucleosides EMORY UNIVERSITY (US) 2018-01-09 US disclosed
US-20160158266-A1 2' FLUORONUCLEOSIDES EMORY UNIVERSITY 2016-06-09 US disclosed
US-9180138-B2 2′-fluoronucleosides UNIVERSITY OF GEORGIA RESEARCH FOUNDATION, INC. (US) 2015-11-10 US disclosed
US-9180138-B2 2′-fluoronucleosides UNIVERSITY OF GEORGIA RESEARCH FOUNDATION, INC. (US) 2015-11-10 US disclosed
US-20130157971-A1 2'-FLUORONUCLEOSIDES SCHINAZI RAYMOND F (US) 2013-06-20 US disclosed
US-20130157971-A1 2'-FLUORONUCLEOSIDES SCHINAZI RAYMOND F (US) 2013-06-20 US disclosed
US-8168583-B2 2-fluoronucleosides UNIVERSITY OF GEORGIA RESEARCH FOUNDATION, INC. (US) 2012-05-01 US disclosed
US-8168583-B2 2-fluoronucleosides UNIVERSITY OF GEORGIA RESEARCH FOUNDATION, INC. (US) 2012-05-01 US disclosed
US-20100173863-A1 2-Fluoronucleosides NATIONAL INSTITUTES OF HEALTH (NIH), U.S. DEPT. OF HEALTH AND HUMAN SERVICES (DHHS), U.S. GOVERNMENT 2010-07-08 US disclosed
US-20100173863-A1 2-Fluoronucleosides NATIONAL INSTITUTES OF HEALTH (NIH), U.S. DEPT. OF HEALTH AND HUMAN SERVICES (DHHS), U.S. GOVERNMENT 2010-07-08 US disclosed
US-RE37449-E1 INCLUDING 1,4-REDUCTION OF DIMERIC IMINIUM INTERMEDIATE TO AN ENAMINE BY REACTION WITH A 1,4-DIHYDROPYRIDINE; OXIDATIVE TRANSFORMATION OF THE PRODUCT TO A SECOND IMINIUM INTERMEDIATE; REDUCTION OF THE SECOND INTERMEDIATE UNIVERSITY OF BRITISH COLUMBIA (CA) 2001-11-13 US disclosed
US-5756531-A ANTIALLERGENS; ANTIINFLAMMATORY AGENTS ABBOTT LABORATORIES (US) 1998-05-26 US disclosed
WO-1997041100-A1 IMINOXY DERIVATIVES OF INDOLE AND INDENE COMPOUNDS AS INHIBITORS OF PROSTAGLANDIN BIOSYNTHESIS ABBOTT LABORATORIES (US) 1997-11-06 WO disclosed
EP-0403909-B1 Method for the production of 2,3-dialkoxypropanals BASF AG (DE) 1994-04-06 EP disclosed
US-5081313-A PROCESS FOR THE PREPARATION OF 2,3-DIALKOXYPROPANALS BASF AKTIENGESELLSCHAFT (DE) 1992-01-14 US disclosed
US-5047528-A Antiviral, Antitumor And Antileukemic Agents UNIVERSITY OF BRISTISH COLUMBIA (CA) 1991-09-10 US disclosed
EP-0403909-A2 Method for the production of 2,3-dialkoxypropanals BASF Aktiengesellschaft (DE) 1990-12-27 EP disclosed
US-4013632-A SYNTHETIC FIBERS PRODUITS CHIMIQUES UGINE KUHLMANN (FR) 1977-03-22 US disclosed